Compare ULBI & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ULBI | CING |
|---|---|---|
| Founded | 1990 | 2012 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.6M | 93.1M |
| IPO Year | 1995 | N/A |
| Metric | ULBI | CING |
|---|---|---|
| Price | $6.50 | $6.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | 65.2K | ★ 636.3K |
| Earning Date | 03-10-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $191,159,000.00 | N/A |
| Revenue This Year | $20.00 | N/A |
| Revenue Next Year | N/A | $556.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.24 | N/A |
| 52 Week Low | $4.07 | $3.20 |
| 52 Week High | $9.51 | $11.89 |
| Indicator | ULBI | CING |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 43.18 |
| Support Level | $6.35 | $3.77 |
| Resistance Level | $7.24 | $6.41 |
| Average True Range (ATR) | 0.43 | 1.10 |
| MACD | 0.05 | -0.34 |
| Stochastic Oscillator | 67.38 | 0.88 |
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.